Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Hepatitis C virus infection

Shepard CW, Finelli L, Alter MJ (2005) Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 5 558-567... [Pg.50]

Abstract In 2007, the world celebrated the 50th anniversary of the discovery of interferon (IFN) by Isaacs and Lindemnann. Subsequently, the IFN-a gene was cloned, fully sequenced and IFN-a was produced in recombinant form. Recombinant IFN-a is now used as the basis for treatment of chronic hepatitis C virus infection and can also be used to treat certain forms of chronic hepatitis B virus infections. IFNs have also been used in other viral infections, although with less success. The antiviral mechanisms of IFNs are reviewed in this chapter as well as the utility of IFNs in the treatment of persistent viral infections. [Pg.204]

Fried MW, Shiftman ML, Reddy KR, Smith C, Marinos G, Goncales EL Jr, Haussinger D, Diago M, Carosi G, Dhumeaux D, Craxi A, Lin A, Hoffman J, Yu J (2002) Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 347 975-982... [Pg.233]

Caniatti EM, Tugnoli V et al (1996) Cryoglobulinemic neuropathy related to hepatitis C virus infection. Clinical, laboratory and neurophysiological study. J Peripher Nerv Syst 1(2) 131-138... [Pg.78]

Kuzushita N, Hayashi N, Kanto T, Ta-kehara T, Tatsumi T, Katayama K et al. Involvement of transporter associated with antigen processing 2 (TAP2] gene polymorphisms in hepatitis C virus infection. Gastroenterology 1999 116[5] 1149-1154. [Pg.80]

Matsushita M, Hijikata M, Ohta Y, Iwata K, Matsumoto M, Nakao K et al. Hepatitis C virus infection and mutations of mannose-binding lectin gene MBL. Arch Virol 1998 143[4] 645—651. [Pg.80]

Newman et al.56 transplant patients with hepatitis C virus infection (Gibco BRL) PCR sensitive and specific method to detect HCV in routine FFPE tissue. [Pg.57]

Cacoub, P, Renou, C., Rosenthal, E., Cohen, P. etal. Extrahepatic manifestations associated with hepatitis C virus infection. Medicine 79 47-56, 2000. [Pg.626]

FIGURE 25-3. Suggested response-optimized chronic hepatitis C virus infection treatment regimens. (Data from Dienstag JL, McHutchinson JG. American Gastroenterological Association technical review of the management of hepatitis C. Gastroenterology 2006 30 231 -264.)... [Pg.293]

Yee, L. J. et al., Tumor necrosis factor gene polymorphisms in patients with cirrhosis from chronic hepatitis C virus infection, Genes Immun., 1, 386, 2000. [Pg.95]

Meyer, R.A., and S.C. Gordon, Epidemiology of hepatitis C virus infection in a suburban Detroit community. Am J Gastroenterol, 1991. 86 1224-6. [Pg.184]

Muga R, Sanvisens F, Bolao F, Tor J, Santes-mases J, Pujol R, Tural C, Tango hr K, Rey-Joly C Munoz A (2006). Significant reductions in HIV prevalence but not of hepatitis C virus infections in injection drug users from metropolitan Barcelona. Drug and Alcohol Dependence, 82, S29-S33... [Pg.166]

Novick DM Kreek MJ (2008). Critical issues in the treatment of hepatitis C virus infection in methadone maintenance patients. Addiction, 103, 905-18... [Pg.166]

Jacobson JM, Feinman L, Liebes L, et al. Pharmacokinetics, safety, and antiviral effects of hypericin, a derivative of St. John s wort plant, in patients with chronic hepatitis C virus infection. Antimicrob Agents Chemother 2001 45 517-524. [Pg.239]

A 62-year-old woman with type 2 diabetes, hypertension, and chronic hepatitis C virus infection developed palpable purpura over her legs and buttocks 3 weeks after starting to take repaglinide 500 mg qds (52). The purpura ulcerated and became infected. Repaglinide was withdrawn and the purpura resolved. A biopsy showed leukocytoclastic vasculitis. [Pg.438]

Hepatitis C virus infection has been associated with diabetes and is a significant risk in patients with renal transplants. In 427 patients with renal transplants and no previous diabetes mellitus, diabetes after transplantation occurred more often in hepatitis C virus-positive than hepatitis C virus-negative patients (39 versus 9.8%)... [Pg.650]

Ghilardi G, Gonvers JJ, So A. Hypothyroid myopathy as a complication of interferon alpha therapy for chronic hepatitis C virus infection. Br J Rheumatol 1998 37(12) 1349—51. [Pg.672]

Welch, P.J., Yei, S. and Barber, J.R. (1998) Ribozyme gene therapy for hepatitis C virus infection. Clin. Diagn. Virol, 10, 163-171. [Pg.65]

Pawlotsky, J. M., 2004, Pathophysiology of hepatitis C virus infection and related liver disease. Trends Microbiol 12, 96-102. [Pg.425]

Hurtova M, Duclos-Vallee JC, Saliba F, Emile JF, Bemelmans M, Castaing D, Samuel D. Liver transplantation for fulminant hepatic failure due to cocaine intoxication in an alcoholic hepatitis C virus-infected patient. Transplantation 2002 73(l) 157-8. [Pg.86]

Taylor MJ, Letendre SL, Schweinsburg BC, A1 Hassoon OM, Brown GG, Gongwatana A, Grant I, and the HNRC. Hepatitis C virus infection is associated with reduced white matter N-acetylaspartate in abstinent methylamphetamine users. J Int Neuropsychol Soc 2004 10 110-3. [Pg.575]

Giannini E, Fasoli A, Chiarbonello B, et al. (2002) 13C-aminopyrine breath test to evaluate severity of disease in patients with chronic hepatitis C virus infection. Aliment Pharmacol Ther 16 717-725. [Pg.129]

Jalan R, Hayes P C 1997 Hepatic encephalopathy and ascites. Lancet 350 1309-1315 Krige J E J, Beckingham IJ 2001 Portal hypertension — 1 varices. British Medical Journal 322 348-351 also Portal hypertension — 2 ascites, encephalopathy, and other conditions. 322 416—418 Koff R S 1998 Hepatitis A. Lancet 351 1643-1649 Lauer G M, Walker B D 2001 Hepatitis C virus infection. [Pg.659]

Sheth, S.G., Flamm, St.L., Gordon, F.D., Chopra, S. AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection. Amer. J. Gastroenterol. 1998 93 44-48... [Pg.122]

Aral, Y., Noda, K., Enomoto, N., Arai, K., Yamada, Y., Suzuki, K., Yoshihara, H. A prospective study of hepatitis C virus infection after needlestick accidents. Liver 1996 16 331 -334... [Pg.456]

Chu, C.-M., Liaw, Y.-F. Simultaneous acute hepatitis B virus and hepatitis C virus infection leading to fulminant hepatitis and subsequent chronic hepatitis C. Clin. Infect. Dis. 1995 20 703-705... [Pg.456]

Datz, C., Cramp, M., Haas, T., Dietze, O., Nitschko, H., Froesner, G., Muss, N., Sandhofer, F., Vogel, W. The natural course of hepatitis C virus infection 18 years after an epidemic outbreak of non-A, non-B hepatitis in a plasmapheresis centre. Gut 1999 44 563-567... [Pg.456]

Delage, G., Infante-Rivard, C., Chiavetta, J.A., Willems, B., Pi, D., Fast, M. Risk factors for acquisition of hepatitis C virus infection in blood donors results of a case-control study. Gastroenterology 1999 116 893-899... [Pg.456]

Delarocque-Astagneau, E., Baffoy, N., Thiers, V., Simon, N., de Valk, H., Laperche, S., Courouce, A.M., Astagneau, R, Buisson, C., Desen-cios, J.C, Outbreak of hepatitis C virus infection in a hemodialysis unit Potential transmission by the hemodialysis machine Infect. Contr. Hosp. Epidem. 2002 23 328—334... [Pg.456]

Feray, C., Gigou, M., Samuel, D., Paradis, V., Wilber, J., David, M.F., Urdea, M., Reynes, M., Brechot, C., Bismuth, H. The course of hepatitis C virus infection after liver transplantation. Hepatology 1994 20 1137-1143... [Pg.456]

Fischler, B., Lindh, G., Lindgren, S., Forsgren, M., von Sydow, M., Sangfelt, R, Alaeus, A., Harland, L., Enockson, E., Nemeth, A. Vertical transmission of hepatitis C virus infection. Scand. X Infect. Dis. [Pg.456]

See other pages where Hepatitis C virus infection is mentioned: [Pg.22]    [Pg.52]    [Pg.203]    [Pg.214]    [Pg.295]    [Pg.342]    [Pg.84]    [Pg.313]    [Pg.34]    [Pg.46]    [Pg.36]    [Pg.153]    [Pg.426]    [Pg.508]    [Pg.493]    [Pg.456]    [Pg.456]    [Pg.457]   


SEARCH



Hepatitis C virus

Hepatitis viruses

Infections hepatitis

Virus infectivity

© 2024 chempedia.info